Characteristics of patients with or without prestroke infection.
Characteristics
Prestroke infection ()
No prestroke infection ()
P
Value
Value
Baseline characteristics
Age, mean, SD (years)
111
74.6 ± 11.8
1834
71.5 ± 12.3
.010
Gender (male), (%)
111
49 (44.1)
1839
843 (45.8)
.769
Premorbid mRS 3–5, (%)
111
17 (15.3)
1833
178 (9.7)
.071
History of stroke, (%)
110
18 (16.4)
1818
283 (15.6)
.788
Hypertension, (%)
109
74 (67.9)
1830
1353 (73.9)
.179
Atrial fibrillation, (%)
110
30 (27.3)
1824
513 (28.1)
.913
Heart failure, (%)
109
37 (33.9)
1814
417 (23.0)
.014
CAD, (%)
110
43 (39.1)
1825
646 (35.4)
.473
Diabetes, (%)
111
25 (22.5)
1823
397 (21.8)
.814
Nicotine use (5 years), (%)
107
21 (19.6)
1822
476 (26.1)
.141
Etiology of IS (TOAST)
111
1839
Atherothrombotic, (%)
16 (14.4)
291 (15.8)
.789
Cardioembolic, (%)
28 (25.2)
484 (26.3)
.912
Lacunar, (%)
16 (14.4)
343 (18.7)
.313
Diffuse lesion (≥1 lobe)
82
33 (40.2)
1110
384 (34.6)
.337
TACI, (%)
110
26 (23.6)
1830
306 (16.7)
.068
Admission SSS, mean, SD
111
29.2 ± 18.0
1836
34.0 ± 17.3
.008
Body temperature day 1, mean (°C)
100
36.8 ± 0.58
1724
36.7 ± 0.43
.033
Mean week body temperature (°C)
80
36.9 ± 0.34
1432
36.8 ± 0.36
.038
Outcome
Recurrent stroke, (%)
111
1 (0.9)
1837
29 (1.6)
.573
30-day SSS, mean, SD
80
43.9 ± 13.9
1564
46.1 ± 13.4
.157
30-day mortality, (%)
111
34 (30.6)
1839
281 (15.3)
<.001
30-day death or dependency, (%)
111
76 (68.5)
1809
957 (52.9)
.002
90-day mortality, (%)
95
39 (41.1)
1601
404 (25.2)
.001
90 day death or dependency, (%)
88
54 (61.4)
1514
743 (49.1)
.028
: the number of patients with available data; SD: standard deviation; mRS: modified Rankin Scale; CAD: coronary artery disease; TACI: total anterior circulation infarction; IS: ischemic stroke; TOAST: Trial of Org 10172 in Acute Stroke Treatment; SSS: Scandinavian Stroke Scale.
